U.S. Pharmacy Benefit Management Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Pharmacy Benefit Management Market 

5.1. COVID-19 Landscape: U.S. Pharmacy Benefit Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Pharmacy Benefit Management Market, By Business Model

8.1. U.S. Pharmacy Benefit Management Market, by Business Model, 2024-2033

8.1.1 Standalone PBM

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Health Insurance Providers

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. U.S. Pharmacy Benefit Management Market, By Service

9.1. U.S. Pharmacy Benefit Management Market, by Service, 2024-2033

9.1.1. Specialty Pharmacy

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Retail Pharmacy

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. U.S. Pharmacy Benefit Management Market, By End-user 

10.1. U.S. Pharmacy Benefit Management Market, by End-user, 2024-2033

10.1.1. Commercial

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Federal

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. U.S. Pharmacy Benefit Management Market, Estimate and Trends Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Business Model (2021-2033)

11.1.2. Market Revenue and Forecast, by Service (2021-2033)

11.1.3. Market Revenue and Forecast, by End-user (2021-2033)

Chapter 12. Company Profiles

12.1. CVS Health

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Cigna

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Optum, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. MedImpact

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Anthem

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Change Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Prime Therapeutics LLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. HUB International Limited.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Elixir Rx Solutions LLC

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Abbott

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms